PL445400A1 - Nowa pochodna 1,3,5-triazyny i jej zastosowanie - Google Patents

Nowa pochodna 1,3,5-triazyny i jej zastosowanie

Info

Publication number
PL445400A1
PL445400A1 PL445400A PL44540023A PL445400A1 PL 445400 A1 PL445400 A1 PL 445400A1 PL 445400 A PL445400 A PL 445400A PL 44540023 A PL44540023 A PL 44540023A PL 445400 A1 PL445400 A1 PL 445400A1
Authority
PL
Poland
Prior art keywords
triazine
application
new derivative
new
derivative
Prior art date
Application number
PL445400A
Other languages
English (en)
Other versions
PL247180B1 (pl
Inventor
Damian Kułaga
Anna Karolina Drabczyk
Izabela SIEMIŃSKA
Original Assignee
Politechnika Krakowska im. Tadeusza Kościuszki
Uniwersytet Rolniczy im. Hugona Kołłątaja w Krakowie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Politechnika Krakowska im. Tadeusza Kościuszki, Uniwersytet Rolniczy im. Hugona Kołłątaja w Krakowie filed Critical Politechnika Krakowska im. Tadeusza Kościuszki
Priority to PL445400A priority Critical patent/PL247180B1/pl
Priority to PCT/IB2024/055994 priority patent/WO2025003836A1/en
Publication of PL445400A1 publication Critical patent/PL445400A1/pl
Publication of PL247180B1 publication Critical patent/PL247180B1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Przedmiotem zgłoszenia jest nowa pochodna tryptamino-1,3,5-triazyny, którą stanowi chlorowodorek N2-(2-(1H-indol-3-ilo)etylo)-6-morfolino-N4-fenetylo-1,3,5-triazyno-2,4-diaminy o wzorze 1 do zastosowania w leczeniu nowotworu jelita grubego.
PL445400A 2023-06-29 2023-06-29 Nowa pochodna 1,3,5-triazyny i jej zastosowanie PL247180B1 (pl)

Priority Applications (2)

Application Number Priority Date Filing Date Title
PL445400A PL247180B1 (pl) 2023-06-29 2023-06-29 Nowa pochodna 1,3,5-triazyny i jej zastosowanie
PCT/IB2024/055994 WO2025003836A1 (en) 2023-06-29 2024-06-19 New 1,3,5-triazine derivative and its application

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL445400A PL247180B1 (pl) 2023-06-29 2023-06-29 Nowa pochodna 1,3,5-triazyny i jej zastosowanie

Publications (2)

Publication Number Publication Date
PL445400A1 true PL445400A1 (pl) 2024-12-30
PL247180B1 PL247180B1 (pl) 2025-05-26

Family

ID=92458268

Family Applications (1)

Application Number Title Priority Date Filing Date
PL445400A PL247180B1 (pl) 2023-06-29 2023-06-29 Nowa pochodna 1,3,5-triazyny i jej zastosowanie

Country Status (2)

Country Link
PL (1) PL247180B1 (pl)
WO (1) WO2025003836A1 (pl)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2451802A1 (en) * 2009-07-07 2012-05-16 Pathway Therapeutics, Inc. Pyrimidinyl and 1,3,5-triazinyl benzimidazoles and their use in cancer therapy
US20130324522A1 (en) * 2010-12-17 2013-12-05 The Rockefeller University Insect odorant receptor antagonists
AU2019299234A1 (en) * 2018-07-05 2021-01-14 Mayo Foundation For Medical Education And Research PIKfyve inhibitors

Also Published As

Publication number Publication date
WO2025003836A1 (en) 2025-01-02
WO2025003836A9 (en) 2025-02-20
PL247180B1 (pl) 2025-05-26

Similar Documents

Publication Publication Date Title
JOP20220142B1 (ar) مثبطات kras g12c
NZ580671A (en) Pyrimidine derivatives
ECSP21077043A (es) Agentes moduladores del regulador de la conductancia transmembrana de la fibrosis quística
CY1117951T1 (el) Αναστολεiς κινασης υποκατεστημενης τριαζινης
PE20211395A1 (es) Proceso de preparacion de dos derivados de 4-{[(2s)-2-{4-[5-cloro-2-(1h-1,2,3-triazol-1-il)fenil]-5-metoxi-2-oxopiridin-1(2h)-il}butanoil]amino}-2-fluorobenzamida
NZ752250A (en) Compounds, devices, and uses thereof
PE20160524A1 (es) Compuestos terapeuticamente activos y sus metodos de uso
PA8595201A1 (es) Preparacion de quinazolinas substituidas
PE20210096A1 (es) Inhibidor de ret para uso en tratar cancer que tiene una alteracion de ret
PE20191108A1 (es) Inhibidores selectivos de jak1
PE20161236A1 (es) Compuesto de triazina y su uso para fines medicos
EA200971069A1 (ru) Метаболиты производных (тио)карбомоилциклогексана
CY1110863T1 (el) Παραγωγα του 2-(8,9-διοξο-2,6-διαζαδικυκλο (5.2.0)-εννε-1(7)-εν-2-υλ)αλκυλ-φωσφονικου οξεος και η χρηση τους ως ανταγωνιστων του ν-μεθυλ- d-ασπαρτικου (nmda) υποδοχεα
PA8571001A1 (es) 2-(2,6-diclorofenil)-diarilimidazoles
DE60206911D1 (de) Imidazol-2-carbonsäureamid derivate als raf-kinase-inhibitoren
AR031152A1 (es) Tratamientos nuevos para el sindrome de piernas inquietas
MA33721B1 (fr) Derives sulfonamides heterocycliques utilises comme inhibiteurs de mek
CY1110343T1 (el) 2-(πυριδιν-2-υλο)-πυριμιδινες και η χρησιμοποιηση του για την καταπολεμηση επιζημιων μυκητων
UY40235A (es) Compuestos de heteroarilo para el tratamiento del dolor
MX2023009060A (es) Antagonistas de gpr84 y usos de estos.
ZA202006071B (en) Antiproliferation compounds and uses thereof
CY1109129T1 (el) Χρηση παραγωγων πυρρολιου για καταπολεμηση του αγχους
PL445400A1 (pl) Nowa pochodna 1,3,5-triazyny i jej zastosowanie
MX2021003732A (es) Inhibidores de menina de molécula pequeña.
PL445404A1 (pl) Nowa pochodna 1,3,5-triazyny i jej zastosowanie